Clinical Trials Logo

Response to Hepatitis A Vaccine clinical trials

View clinical trials related to Response to Hepatitis A Vaccine.

Filter by:
  • None
  • Page 1

NCT ID: NCT01360970 Completed - Clinical trials for Response to Hepatitis A Vaccine

Hepatitis A Vaccine in Patients With Immunomodulating Drugs

Start date: September 2009
Phase: Phase 2
Study type: Interventional

Hepatitis A vaccine is the most frequently used traveller's vaccine, yet data on its ability to induce protective immunity in immunosuppressed travellers are scarce. The investigators assess the hepatitis A virus (HAV) antibody response in patients with rheumatoid arthritis (RA) treated with Tumor Necrosis Factor (TNF) - inhibitors and/or methotrexate (Mtx).